search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
XII AAEP News April 2018


INDUSTRY


U.S. horse industry study: Economic impact up, horse population down Results to help define industry’s importance among legislators, general public


The United States equine industry generates approximately $122 billion in total economic impact, according to results of the 2017 Economic Impact Study of the U.S. Horse Industry released in early March by the American Horse Council Foundation. The total is an increase of nearly 20% on the approximately $102 billion impact identified when the study was last conducted in 2005.


During the same time, the number of horses dropped from 9.2 million to 7.2 million, a not-unexpected decrease due to recent declines in breed registration trends. Texas, California and Florida continue to have the highest population of horses.


The study also determined the industry provides a total


employment impact of 1.74 million and generates $79 billion in total salaries, wages and benefits. In


addition, 38 million, or 30.5%, of U.S. households contain a horse enthusiast, and 38% of participants are under the age of 18.


“Having these updated numbers is critical not only to the AHC’s efforts up on Capitol Hill, but also for the industry to demonstrate to the general public how much of a role the equine has in American


households,” said AHC President Julie Broadway.


The full national study, along with breakout studies for 15 states, is available for purchase through the AHC website at horsecouncil.org/ horsecouncil-publications. The AAEP was among the many equine industry organizations to provide funding support for the survey.


AAEP Educational Partner Profile: Luitpold Pharmaceuticals Luitpold Animal Health, a division of Luitpold Pharmaceuticals, Inc., the manufacturer of Adequan®


glycosaminoglycan) and BetaVet®


i.m. (polysulfated (betamethasone sodium phosphate & betamethasone acetate injectable suspension),


has proudly sponsored the AAEP as an Educational Partner since 2008. Our long-term support of the AAEP initiatives is based on our shared interest in equine health. We applaud the involvement of the AAEP and of their member equine veterinarians in helping to ensure the proper diagnosis and treatment of equine health.


In addition to the AAEP, Luitpold Animal Health supports the equine industry through a number of other contributions to equine veterinary organizations. Some of our other support initiatives include the Northeast Association of Equine Practitioners, the Texas Equine Veterinary Association, the Florida Association of Equine Practitioners, and the American Association of Equine Veterinary Technicians.


This year, Adequan i.m. is celebrating its 29th year as the only FDA-approved equine polysulfated glycosaminoglycan. Whether to treat companion horses or equine athletes, Luitpold Animal Health is dedicated to supporting your equine’s health.


Dr. Eleanor Green


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80